首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   813篇
  免费   50篇
  国内免费   86篇
耳鼻咽喉   2篇
儿科学   19篇
妇产科学   4篇
基础医学   46篇
口腔科学   11篇
临床医学   110篇
内科学   134篇
皮肤病学   6篇
神经病学   10篇
特种医学   23篇
外科学   220篇
综合类   27篇
预防医学   24篇
眼科学   36篇
药学   145篇
中国医学   49篇
肿瘤学   83篇
  2023年   1篇
  2022年   6篇
  2021年   16篇
  2020年   9篇
  2019年   15篇
  2018年   20篇
  2017年   16篇
  2016年   14篇
  2015年   12篇
  2014年   19篇
  2013年   28篇
  2012年   33篇
  2011年   35篇
  2010年   27篇
  2009年   36篇
  2008年   48篇
  2007年   97篇
  2006年   46篇
  2005年   46篇
  2004年   32篇
  2003年   31篇
  2002年   33篇
  2001年   43篇
  2000年   30篇
  1999年   26篇
  1998年   28篇
  1997年   26篇
  1996年   23篇
  1995年   18篇
  1994年   14篇
  1993年   13篇
  1992年   15篇
  1991年   13篇
  1990年   16篇
  1989年   17篇
  1988年   9篇
  1987年   7篇
  1986年   6篇
  1985年   7篇
  1984年   4篇
  1983年   1篇
  1979年   1篇
  1978年   1篇
  1977年   1篇
  1976年   2篇
  1975年   1篇
  1973年   5篇
  1972年   1篇
  1968年   1篇
排序方式: 共有949条查询结果,搜索用时 15 毫秒
941.
A series of monoclonal antibodies recognizing myeloid differentiation antigens were prepared by immunizing Balb/c mice with HL-60 cells. Hybrids secreting antibodies reactive with HL-60 cells but unreactive with peripheral blood mononuclear cells were isolated and further cloned. One clone was found to produce an IgG2a antibody recognizing an 85,000-dalton molecular weight surface glycoprotein, and a second clone was found to produce an IgM antibody recognizing a heat-stable determinant present on a glycolipid. We have termed these antigens Pro- Im1 and Pro-Im2, respectively (Pro for using HL-60 promyelocytes as an immunogen and Im for the presence of these antigens on immature cells). alpha Pro-Im1 and alpha Pro-Im2 were used to investigate the surface expression and tissue distribution of these two antigens. Pro-Im1 and Pro-Im2 were found to be brightly expressed on a fraction of fetal liver hematopoietic and bone marrow cells. Both antibodies mediated complement-dependent inhibition of CFU-GM, BFU-E, and CFU-GEMM formation assayed by soft agar colony and burst formation, indicating the expression of these antigens by early hematopoietic precursor cells. This was further confirmed by the induction of HL-60 cells by TPA to differentiate into more mature monocytes and macrophages, accompanied by the loss of both antigens. Pro-Im1 and Pro-Im2 were absent from peripheral blood monocytes, erythrocytes, and platelets, but Pro-Im2 was expressed on granulocytes. Both antigens were absent from thymocytes and peripheral T cells. Cytofluorographic analysis suggested their absence from peripheral blood B cells but that both were expressed on a minority of tissue B cells. Analysis of 150 cases of various myeloid and lymphoid malignancies demonstrated Pro-Im1 and Pro-Im2 expression on myeloblasts and promyelocytes from some acute myelogenous leukemias as well as some B cell malignancies, suggesting that these antigens are shared by early hematopoietic cells and a subset of B cells.  相似文献   
942.
Adenoviral gene therapy represents a novel approach for the treatment of aggressive thyroid carcinomas. Both coxsackie-adenovirus receptor (CAR) and integrins have been shown to be the major determinants for adenoviral infectivity in many types of cancer cells, yet conflicting results have been reported. In this report we examine these factors mediating adenoviral infection in thyroid cells and to evaluate CAR expression in various types of thyroid cancer. We found that neither expression levels of CAR nor integrins are solely predictive of adenoviral infectivity in thyroid cells. However, the absence of CAR was associated with poor adenoviral infectivity in immortalized rat FRTL-5 cells. Moreover, preincubation with alpha-CAR antibody decreased infectivity in FTC 238 cells, a human thyroid tumor line. These results indicate that CAR does play a role in adenoviral infection of thyroid cells. Immunohistochemical analysis revealed that CAR is expressed at the cell surface in the majority of malignant thyroid tumors. We further show that adenoviral infectivity in some thyroid cancer cells can be improved by poly-L-lysine. Our study warrants a functional method to evaluate adenoviral infectivity should be developed and instituted prior to clinical trials of adenoviral gene therapy in patients with advanced thyroid cancer.  相似文献   
943.
目的:观察胰岛素对严重烧伤所致的急性肺损伤的保护效应。方法:实验于2006-01/08在解放军第四军医大学西京医院全军烧伤中心实验室完成。取成年雄性SD大鼠36只,随机分成3组,每组12只:①烫伤 胰岛素组:水浴锅94℃,20s,制备30%总体表面积全层皮肤烫伤模型,伤后即刻腹腔注射生理盐水40mL/kg,并皮下注射胰岛素3U/kg。②烫伤组:造模和腹腔注射同烫伤 胰岛素组,皮下注射等体积生理盐水。③假烫组:用室温水浴模拟烫伤过程,伤后不给予补液。烫伤24h后,收集动脉血测定超氧化物歧化酶活性,收集支气管肺泡灌洗液测定蛋白含量,取肺组织进行苏木精-伊红染色观察病理变化,并测定髓过氧化物酶活性,同时电镜观察胸主动脉血管内皮细胞变化情况。结果:36只大鼠进入结果分析。①肺病理变化:烫伤 胰岛素组肺脏渗出和水肿较烫伤组明显减轻。②肺泡灌洗液中蛋白的质量浓度:烫伤组和烫伤 胰岛素组高于假烫组[(702.9±169.5),(486.5±149.2),(240.5±140.7)mg/L,P<0.05],烫伤 胰岛素组低于烫伤组(P<0.05)。③肺脏髓过氧化物酶活性:烫伤 胰岛素组低于烫伤组[(36.01±8.17),(59.51±12.50)nkat/g,P<0.05],与假烫组比较差异不显著。④血清超氧化物歧化酶活性:烫伤组和烫伤 胰岛素组低于假烫组[(2.27±0.18),(2.63±0.19),(2.81±0.21)mkat/L,P<0.01,0.05],烫伤 胰岛素组高于烫伤组(P<0.01)。⑤电镜下可见烫伤 胰岛素组内皮细胞损伤较烫伤组轻。结论:严重烧伤早期外源性胰岛素干预后可减轻急性肺损伤,具有明显的肺脏保护作用,这种作用可能与胰岛素的内皮细胞保护效应有关。  相似文献   
944.
945.
BACKGROUND: Therapeutic monitoring of lithium is important because of its narrow therapeutic range and therapeutic index, low protein binding and single route of elimination. We characterized a new photometric method that avoids the specialized requirements of ion-specific electrode (ISE), atomic absorption and flame emission methods. METHODS: Minimum detectable concentration (MDC), linearity and calibration drift over 65 days were determined. Within-run, between-run and total imprecision were assessed over 20 days in accordance with NCCLS EP5. Interference studies were conducted for 46 endogenous and exogenous compounds. Two production lots of the new photometric method (LI) were compared on the Dimension(R) RxL system and two ISE methods [Ciba Corning (n=124) and DuPont (n=131)], an established photometric method (Vitros) 950 system; n=63) and atomic absorption (Thermo-Jerell Ash; n=63). RESULTS: The MDC was 0.04 mmol/l. Linearity was demonstrated from 0.12 to 5.8 mmol/l by the regression equation: observed=(1.01 x expected)-0.0005 mmol/l, S(y/x)=0.03 mmol/l, r=0.999. Drift for the lithium calibrators over the 65-day study period was <5%, except for the lowest calibrator, which showed 0.04 mmol/l drift. None of the 46 potential interfering substances showed greater than a 6.5% difference between control and test solutions. ISE method comparisons showed the following: LI=(1.08 x Ciba Corning ISE)-0.15 mmol/l, S(y/x)=0.05, r=0.999, and LI=(1.03 x DuPont ISE)+0.00 mmol/l, S(y/x)=0.06 mmol/l, r=0.999. Comparison of the LI method with the atomic absorption and Vitros system showed proportionality error <10%. Bias between the LI method and atomic absorption was 7%, substantially less than that documented in proficiency surveys for the Vitros and other systems. No lot-to-lot or site-to-site differences were observed. CONCLUSION: This new photometric method is an attractive alternative for Li measurement and is adaptable to instruments having spectrophotometric capability.  相似文献   
946.
Background: The risk factors for the recurrent choledocholithiasis after endoscopic retrograde cholangiopancreatography(ERCP) have not been well studied. The aim of this study was to explore the risk factors of recurrent choledocholithiasis. Methods: We carried out a retrospective analysis of data collected between January 1, 2010 and January 1, 2020. Univariate analysis and multivariate analysis were used to explore the independent risk factors of recurrent choledocholithiasis following therape...  相似文献   
947.
The aim of this study was to introduce Ag–Cu phase nanopowder as an additive to improve the corrosion behavior of dental amalgams. A novel Ag–Cu nanopowder was synthesized by the precipitation method. An amalgam alloy powder (World-Cap®) was added and mixed with 5 wt.% and 10 wt.% of Ag–Cu nanopowders, respectively, to form experimental amalgam alloy powders. The original alloy powder was used as a control. Alloy powders were examined using X-ray diffraction, transmission electron microscopy (TEM), scanning electron microscopy and electron probe microanalysis. Amalgam disk specimens of metallurgically prepared were tested in 0.9% NaCl solution using electrochemical methods. The changes in the corrosion potential and anodic polarization characteristics were determined. Corrosion potential data were analyzed statistically (n = 3, analysis of variance, Tukey’s test, p < 0.05). The diameters of lamellar structure Ag–Cu nanoparticles were measured to be approximately 30 nm. The composition of the Ag–Cu nanoparticles determined by TEM–energy-dispersive spectroscopy was 56.28 at.% Ag–43.72 at.% Cu. A light-shaded phase was found mixing with dark Cu–Sn reaction particles in the reaction zones of Ag–Cu nanoparticle-doped amalgams. The Ag–Cu nanoparticle-doped amalgams exhibited zero current potentials more positive than the control (p < 0.05) and no current peak was observed at −325 mV that related to Ag–Hg phase and Cu6Sn5 phase in anodic polarization curves. The results indicated that the corrosion resistance of high-copper single-composition amalgam could be improved by Ag–Cu nanoparticle-doping.  相似文献   
948.
949.

Introduction

Complete molecular response (CMR) and 2- and 3-year overall survival (OS) were compared for patients with newly diagnosed Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) who had undergone front-line combination chemotherapy plus ponatinib versus combination therapy plus earlier generation tyrosine kinase inhibitors (TKIs; imatinib, dasatinib, and nilotinib).

Patients and Methods

We identified 26 Ph+ ALL studies: 25 of earlier generation TKIs and 1 of ponatinib. The outcomes from studies of combination chemotherapy plus earlier generation TKIs were summarized using pooled estimates with 95% confidence intervals (CIs) from a random-effects meta-analysis. A binomial distribution was assumed to calculate the 95% CIs for the results from the single-arm combination chemotherapy plus ponatinib trial. Adjusted logistic meta-regression analyses were used to compare the outcomes between the TKI groups.

Results

The percentage of patients achieving a CMR was greater with combination chemotherapy plus ponatinib (79%) than the pooled percentage of patients achieving a CMR with combination chemotherapy plus earlier generation TKIs (34%). Greater OS was observed with ponatinib compared with the pooled OS for earlier generation TKIs (2-year, 83% vs. 58%; 3-year, 79% vs. 50%). Odds ratios for ponatinib versus earlier generation TKIs were 6.09 (95% CI, 1.16-31.90; P = .034) for CMR, 3.70 (95% CI, 0.93-14.73; P = .062) for 2-year OS, and 4.49 (95% CI, 1.00-20.13; P = .050) for 3-year OS.

Conclusion

Ponatinib plus chemotherapy might be associated with better outcomes than chemotherapy with earlier generation TKIs in patients with newly diagnosed Ph+ ALL.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号